Axsome Therapeutics, Inc. (AXSM)
183.93
-0.25
(-0.14%)
USD |
NASDAQ |
Apr 16, 13:10
Axsome Therapeutics Research and Development Expense (Quarterly) : 48.68M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| Amicus Therapeutics, Inc. | 23.74M |
| Insmed, Inc. | 254.91M |
| MannKind Corp. | 27.59M |